Transvaginal ultrasonographic assessment of the endometrium in asymptomatic, postmenopausal women using different HRT regimens containing tibolone or estrogen

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 49, Issue 11, 2004, Pages 893-898

  Kurtay, Gulay ^a   Berker, Bulent ^a,b   Demirel, Cem ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b Huseyinonat Sokak 10/6 Sahinbey Ap ^*  (Turkey)

Author keywords

Endometrium; Hormone replacement therapy; Postmenopause; Tibolone; Ultrasonography

Indexed keywords

ESTRADIOL; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; TIBOLONE;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM ATROPHY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEASUREMENT; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; TRANSVAGINAL ECHOGRAPHY; VAGINA BLEEDING;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ATROPHY; ENDOMETRIUM; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; NORPREGNENES; POSTMENOPAUSE; RETROSPECTIVE STUDIES; VAGINA;

EID: 9344265183     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Barnabei VM, Grady D, Stovall DW, et al: Menopausal symptoms in older women and the effects of treatment with hormone therapy. Obstet Gynecol 2002;100:1209-1218
2. Compston JE: Hormone replacement therapy for osteoporosis: Clinical and pathophysiological aspects. Reprod Med Rev 1994;3:209-224
3. Doren M: Hormonal replacement regimens and bleeding. Maturitas 2000;34:17-23
4. Bornstein J, Auslender R, Goldstein S, et al: Increased endometrial thickness in women with hypertension. Am J Obstet Gynecol 2000;183:583-587
5. Gull B, Karlsson B, Milsom I, et al: Factors associated with endometrial thickness and uterine size in a random sample of postmenopausal women. Am J Obstet Gynecol 2001;185:386-391
6. Persadie RJ: Ultrasonographic assessment of endometrial thickness: A review. J Obstet Gynaecol Can 2002;24:131-136
7. Affinito P, Palomba S, Sammartino A, et al: Ultrasonographic endometrial monitoring during continuous-sequential hormonal replacement therapy regimen in postmenopausal women. Maturitas 2001;39:239-244
8. Moore RA: Livial: A review of clinical studies. Br J Obstet Gynaecol (suppl 19) 1999;106:1-21
9. Fleischer AC, Wheeler JE, Lindsay I, et al: An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms. Am J Obstet Gynecol 2001;184:70-74
10. Smith-Bindman R, Kerlikowske K, Feldstein VA, et al: Endovaginalultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 1998;280:1510-1517
11. Holbert TR: Transvaginal ultrasonographic measurement of endometrial thickness in postmenopausal women receiving estrogen replacement therapy. Am J Obstet Gynecol 1997; 176:1334-1339
12. Bourne T, Hamberger L, Hahlin M, et al: Ultrasound in gynecology: Endometrium. Int J Gynaecol Obstet 1997;56:115-127
13. Neslihan Carda S, Bilge SA, et al: The menopausal age, related factors and climacteric symptoms in Turkish women. Maturitas 1998;30:37-40
14. Cano A: Compliance to hormone replacement therapy in menopausal women controlled in a third level academic center. Maturitas 1994; 20:91-99
15. Van Gorp T, Neven P: Endometrial safety of hormone replacement therapy: Review of literature. Maturitas 2002; 42:93-104
16. Fistonic I, Hodek B, Klaric P, et al: Transvaginal sonographic assessment of premalignant and malignant changes in the endometrium in postmenopausal bleeding. J Clin Ultrasound 1997;25:431-435
17. Varner RE, Sparks JM, Cameron CD, et al: Transvaginal sonography of the endometrium in postmenopausal women. Obstet Gynecol 1991;78:195-199
18. Karlsson B, Granberg S, Wikland M, et al: Transvaginal ultrasonography of the endometrium in women with post-menopausal bleeding: A Nordic multicenter study. Am J Obstet Gynecol 1995;172:1488-1493
19. Langer R, Pierce J, O'Hanlan K, et al: Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. N Engl J Med 1997;337:1792-179
20. Archer D, McIntyre-Seltman K, Wilborn W, et al: Endometrial morphology in asymptomatic postmenopausal women. Am J Obstet Gynecol 1991;165:317-322
21. Korhonen MO, Symons JP, Hyde BM, et al: Histologic classification and pathologic findings for endometrial biopsy specimens obtained from 2964 perimenopausal and post-menopausal women undergoing screening for continuous hormones as replacement therapy (CHART 2 Study). Am J Obstet Gynecol 1997;176:377-380
22. Castelo-Branco C, Puerto B, Duran M, et al: Transvaginal sonography of the endometrium in postmenopausal women: Monitoring the effect of hormone replacement therapy. Maturitas 1994;19:59-65
23. Lin M, Gosink B, Wolf S, et al: Endometrial thickness after menopause: Effect of hormone replacement. Radiology 1991; 180:427-432
24. Doren M, Rubig A, Coelingh Bennink HJ, et al: Impact on uterine bleeding and endometrial thickness: Tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy. Menopause 1999;6:299-306
25. Hanggi W, Bersinger N, Altermatt HJ, et al: Comparison of transvaginal ultrasonography and endometrial biopsy in endometrial surveillance in postmenopausal HRT users. Maturitas 1997;27:133-143
26. Stadberg E, Mattsson LA, Uvebrant M. 17β-Estradiol and norethisterone acetate in low doses as continuous combined replacement therapy. Maturitas 1996;23:31-39
27. Hammar M, Christau S, Nathorst-Boos J, et al: A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in post-menopausal women with menopausal symptoms. Br J Obstet Gynaecol 1998;105:904-911